Paul Desert (Paul Désert)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Herpes Simplex Virus

Plasmodium Falciparum

Top Venues

Journal of applied toxicology : JAT

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Karine Broudic, Sébastien Laurent, Vladimir Perkov, Charlene Simon, Marie Garinot, Nathalie Truchot, Julie Latour, Paul Desert
Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistribution. Journal of applied toxicology : JAT (2023)
Fabienne Piras, Lisa M Plitnick, Peter Berglund, Marie-Clotilde Bernard, Paul Desert
Nonclinical safety evaluation of two vaccine candidates for herpes simplex virus type 2 to support combined administration in humans. Journal of applied toxicology : JAT (2022)
James M Murithi, Cécile Pascal, Jade Bath, Xavier Boulenc, Nina F Gnädig, Charisse Flerida A Pasaje, Kelly Rubiano, Tomas Yeo, Sachel Mok, Sylvie Klieber, Paul Desert, María Belén Jiménez-Díaz, Jutta Marfurt, Melanie Rouillier, Mohammed H Cherkaoui-Rbati, Nathalie Gobeau, Sergio Wittlin, Anne-Catrin Uhlemann, Richard N Price, Grennady Wirjanata, Rintis Noviyanti, Patrick Tumwebaze, Roland A Cooper, Philip J Rosenthal, Laura M Sanz, Francisco Javier Gamo, Jayan Joseph, Shivendra Singh, Sridevi Bashyam, Jean Michel Augereau, Elie Giraud, Tanguy Bozec, Thierry Vermat, Gilles Tuffal, Jean-Michel Guillon, Jérôme Menegotto, Laurent Sallé, Guillaume Louit, Marie-José Cabanis, Marie Françoise Nicolas, Michel Doubovetzky, Rita Merino, Nadir Bessila, Inigo Angulo-Barturen, Delphine Baud, Lidiya Bebrevska, Fanny Escudie, Jacquin C Niles, Benjamin Blasco, Simon Campbell, Gilles Courtemanche, Laurent Fraisse, Alain Pellet, David A Fidock, Didier Leroy
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance. Science translational medicine 13 (603) (2021)